The pharmaceutical industry, particularly Pharmacy Benefit Managers (PBMs), is under scrutiny for deceptive business practices that prioritize profits over patient care. Mark Cuban highlights five ways PBMs harm U.S. healthcare and suggests solutions. Cuban also comments on the reluctance of weight-loss drug manufacturers to sell through certain channels, prompting further investigation into the pharmacy business.
This is how bad the pharmacy business is https://t.co/KwkRlpQdW0
We asked @mcuban why Ozempic and other weight-loss drug manufacturers won't sell through @costplusdrugs. "I can only guess," he wrote. "You should ask them." So, naturally, we did exactly that: https://t.co/kGCznB4Oq2 https://t.co/iSOgRXMJi4
Shark Tank’s Mark Cuban speaks out on Ozempic, weight-loss drugs https://t.co/6FQUyJa5qW
From Mark Cuban @mcuban: Five Ways that Big hashtag#PBMs Hurt U.S. Healthcare–And How We Can Fix It A Drug Channels exclusive op-ed from the founder of @costplusdrugs ==> https://t.co/WKushOjprI
From Mark Cuban @mcuban: Five Ways that Big hashtag#PBMs Hurt U.S. Healthcare–And How We Can to Fix It A Drug Channels exclusive op-ed from the founder of @costplusdrugs ==> https://t.co/WKushOjprI https://t.co/WKushOjprI
From Mark Cuban @mcuban : Five Ways that Big hashtag#PBMs Hurt U.S. Healthcare–And How We Can to Fix It A Drug Channels exclusive op-ed from the founder of @costplusdrugs ==> https://t.co/WKushOjprI https://t.co/WKushOjprI
"PBMs hold considerable power to change contract terms if their own bottom line suddenly is at risk." The deceptive business practices outlined in this @statnews story illustrate the lengths the PBM industry will go to protect their bottom lines, even at the expense of patients… https://t.co/El2AfbXfZr
BOCHI MCKINNEY: Big Pharma is hypocritical and corrupt https://t.co/abDAzw1Bcg